Adaptive Biotechnologies

ADAPTIVE THERAPEUTICS

Targeted T-cell receptor sequences, engineered T-cell receptor sequences, and therapeutics derived from natural T-cell receptor sequences for use in the treatment of cancer, autoimmune disease and infectious diseases;Scientific research, development and analytical services for discovery and identification of T-cell receptor sequences specific for an antigen or for development or use as a therapeutic, therapeutic target or biomarker; scientific research, development, and analytical services in the fields of medicine, oncology, auto-immune disorders, infectious diseases, immunology, immunotherapies, immunopharmaceuticals, immune repertoire sequencing, T-cell therapeutics, therapeutics, and therapeutic technologies;

TCRSEQ

Development of new technology for others in the field of biotechnology; DNA analysis services; DNA screening for scientific research purposes; Genetic testing for scientific research purposes; Genome amplification; Genotyping services for research or analysis purposes; Laboratory research in the field of immune sequencing; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of immune sequencing; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and analysis in the field of medicine; Research and development in the pharmaceutical and biotechnology fields; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Scientific research in the field of genetics and genetic engineering;